Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects

Study Title

Pharmacokinetics and Pharmacodynamics (PK/PD) of CEP-26401 in Healthy Subjects

Teva Identifier

C26401/1111 | 2013-001883-51

ClinicalTrials.gov Identifier

NCT01903824

Study Status

Completed

Trial Condition(s)

Cognitive Impairment

Interventions

Drug: CEP-26401 | Drug: donepezil hydrochloride | Drug: modafinil | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 50 Years

Trial Duration

08/01/2013 - 12/01/2013

Phase

Phase 1

Study Type

Interventional